An FDA committee will meet today to discuss possibly granting the Johnson & Johnson single-dose COVID-19 vaccine emergency use authorization.
KDKA's Lindsay Ward has more on the new vaccine.
An FDA committee will meet today to discuss possibly granting the Johnson & Johnson single-dose COVID-19 vaccine emergency use authorization.
KDKA's Lindsay Ward has more on the new vaccine.
According to an April 2024 press release, Alvotech and Teva's Selarsdi™ (ustekinumab-aekn) was approved by the FDA on April 16 as..